Changeflow GovPing Government & Legislation DEA Withdraws Marijuana Rescheduling Proposal
Priority review Rule Amended Final

DEA Withdraws Marijuana Rescheduling Proposal

Email

Summary

The Drug Enforcement Administration (DEA) has withdrawn its proposed rule to reschedule marijuana under the Controlled Substances Act. Marijuana remains classified as a Schedule I controlled substance, maintaining the most restrictive federal designation. There is no new compliance obligation imposed and no change to the current legal status of marijuana.

Published by DEA on federalregister.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors US Federal Register — Public Inspection Desk for new government & legislation regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 38 changes logged to date.

What changed

DEA has withdrawn its proposed rule to reschedule marijuana from Schedule I to a lower schedule under the Controlled Substances Act. The withdrawal reverses the prior proposed action and confirms that marijuana retains its Schedule I classification, which defines it as having a high potential for abuse and no accepted medical use under federal law.

Cannabis businesses and DEA registrants should continue operating under existing Schedule I compliance frameworks. The withdrawal signals no near-term change to the regulatory posture of marijuana under federal law, though stakeholders should monitor for future administrative action.

Archived snapshot

Apr 27, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Public Inspection :: Proposed Rule

Schedules of Controlled Substances: Rescheduling of Marijuana; Withdrawal

An unpublished Proposed Rule
by the Drug Enforcement Administration on 04/28/2026

  • Document Details
  • Sharing Public Inspection Document This document is unpublished. It is scheduled to be published on 04/28/2026.

Once it is published it will be available on this page in an official form.
Until then, you can download the unpublished PDF version.

Although we make a concerted effort to reproduce the original document
in full on our Public Inspection pages, in some cases graphics may not
be displayed, and non-substantive markup language may appear alongside
substantive text. If you are using public inspection listings for legal
research, you should verify the contents of documents against a final,
official edition of the Federal Register. Only official editions of the Federal Register provide legal
notice of publication to the public and judicial notice to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.

Public Inspection Document

Get daily alerts for US Federal Register — Public Inspection Desk

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from DEA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
DEA
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
4453 Cannabis
Activity scope
Controlled substance scheduling Regulatory withdrawal
Geographic scope
United States US

Taxonomy

Primary area
Cannabis
Operational domain
Regulatory Affairs
Topics
Pharmaceuticals

Get alerts for this source

We'll email you when US Federal Register — Public Inspection Desk publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!